Genethera and leading Italian research institute finalize collaboration agreement on mad-cow & other animal diseases

UK - GeneThera, Inc. (OTCBB:GTHA) is pleased to announce the finalization, subject to final translation, of a Collaboration Agreement with Italy's leading applied research laboratory, Istituto Zooprofilattico Sperimentale della Lombardia e dell ´ Emilia Romagna (IZSLER) to collaborate on scientific research related to the diagnosis of animal transmittable diseases, such as Mad-Cow and Scrapie diseases.
calendar icon 11 October 2006
clock icon 2 minute read

The Parties to this Agreement will endeavor to validate GeneThera's proprietary technology by comparing 10,000 samples between GeneThera's developed test and an approved Post Mortem test under ESFA guidelines for validation. Basically, GeneThera will be responsible for supervising all aspects of the testing under this Agreement, while the Institute will provide its facilities and assist in the accreditation and validation of the tests and technology of GeneThera.
The Agreement will allow for the (i) establishment of validation protocols to compare GeneThera's live animal blood test technology for the detection of Transmissible Spongiform Encephalopathy ( "TSE" ) to current available methodologies for "post mortem detection" of TSE; (ii) to establish a research protocol for a time course correlation study between the TSE-specific gene marker expression levels in blood and the presence of TSE in live experimentally infected animals, and (iii) to establish a Bovine Spongiform Encephalopathy ( "BSE" ) screening program using GeneThera's live animal blood test system for large scale cattle testing in feedlots and slaughter houses.
In conjunction with this announcement, IZSLER has begun collecting the first samples from the Institutes's experimentally infected cattle herd with GeneThera's Field Collection System ™ for review by GeneThera's staff.
Dr. Tony Milici, CEO of GeneThera remarked, "This is a banner day for our Company. The long-awaited day for us to begin large scale validation of our live test for detection of TSE is at hand. We have waited many years for this opportunity and are extremely excited what the start of this validation means to GeneThera and to the future of BSE testing."

TheCattleSite News Desk

© 2000 - 2022 - Global Ag Media. All Rights Reserved | No part of this site may be reproduced without permission.